Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus [0.03%]
1型和2型糖尿病患者血糖控制与糖尿病相关住院费用的关系
Joseph Menzin,Jonathan R Korn,Joseph Cohen et al.
Joseph Menzin et al.
Background: Diabetes mellitus requires continuous medical care and patient self-management in order to prevent short-term complications and decrease the risk of long-term complications, which can result in substantial inc...
Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program [0.03%]
北卡罗来纳州医疗补助计划中一项立竿见影的质子泵抑制剂预授权方案与药剂师和医师满意度及转换为首选药物的速度相关性研究
Julie C Jacobson Vann,Stephanie Christofferson,Charles G Humble et al.
Julie C Jacobson Vann et al.
Background: Proton pump inhibitors (PPIs) are among the highest expenditure drugs covered by health care plans. During fiscal year 2001-2002, Medicaid programs nationwide spent nearly $2 billion on PPIs. Although the cost...
Variation in prescriber responses to drug safety alert messages: disease, symptom, or red herring? [0.03%]
药物安全警示信息在处方者中的不同反应：病因、症状还是误导？
Daniel A Ollendorf
Daniel A Ollendorf
Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types [0.03%]
预防宫颈癌和相关宫颈疾病：针对致癌型人乳头瘤病毒的疫苗接种的成本效益分析综述
Edward P Armstrong
Edward P Armstrong
Background: Vaccines have demonstrated cost-effectiveness in managed care through the prevention of disease. As new vaccines for previously untargeted conditions are developed, pharmacoeconomic modeling is becoming even m...
Gender differences in self-reported symptom awareness and perceived ability to manage therapy with disease-modifying medication among commercially insured multiple sclerosis patients [0.03%]
多发性硬化症患者中报告的症状意识和管理疾病修正药物治疗能力的感知方面的性别差异:一项商业保险研究
Anna Vlahiotis,Rebecca Sedjo,Emily R Cox et al.
Anna Vlahiotis et al.
Background: Multiple sclerosis (MS) is a chronic, neurodegenerative inflammatory disease that affects approximately 400,000 Americans, the majority of whom are female. Although MS prevalence is higher among females, males...
Geographic variation in drug safety: potentially unsafe prescribing of medications and prescriber responsiveness to safety alerts [0.03%]
药物安全的地域差异：药物潜在不安全处方及对安全性警告的响应度
Richard A Feifer,Jason M James
Richard A Feifer
Background: Drug safety issues represent a major cause of morbidity and mortality. Alerting programs are intended to identify patients at potential risk for adverse drug reactions and may provide relevant information to p...
Medication therapy management: 10 years of experience in a large integrated health care system [0.03%]
药物治疗管理：大型综合医疗系统中十年的经验教训
Djenane Ramalho de Oliveira,Amanda R Brummel,David B Miller
Djenane Ramalho de Oliveira
Background: Medication therapy management (MTM) was officially recognized by the federal government in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, which requires Medicare Part D plans that ...
Interpreting hazards: the increasing importance of "antidote to anecdote" in managed care [0.03%]
危害解释：“以子之矛，攻子之盾”在管理护理中越来越重要
Kathleen A Fairman
Kathleen A Fairman
Is value-based value wasted? Examining value-based insurance designs through the lens of cost-effectiveness [0.03%]
基于价值的保险设计的成本效益分析
Steven J Melnick,Brenda R Motheral
Steven J Melnick
Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization [0.03%]
在一个大型的管理式医疗组织中关于住院开始并继而在门诊持续使用的质子泵抑制剂应激性溃疡预防治疗相关的成本纵向分析
Lisa Thomas,Eric J Culley,Patricia Gladowski et al.
Lisa Thomas et al.
Background: Proton pump inhibitor (PPI) therapy is commonly initiatedin hospitals for a variety of reasons including stress ulcer prophylaxis. Outpatient use of inpatient-initiated PPI use may be medically unwarranted. ...